QR 060127
Alternative Names: QR-060127Latest Information Update: 28 Apr 2026
At a glance
- Originator Wuhan Createrna Science and Technology
- Class Analgesics; Anti-inflammatories; Antitussives; Urologics
- Mechanism of Action Transient receptor potential channel inhibitors
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cough; Focal segmental glomerulosclerosis; Inflammatory pain
Most Recent Events
- 28 Apr 2026 No recent reports of development identified for preclinical development in Focal-segmental-glomerulosclerosis in China (PO, Capsule)
- 28 Apr 2026 No recent reports of development identified for preclinical development in Inflammatory-pain in China (PO, Capsule)
- 28 Aug 2025 No recent reports of development identified for phase-I development in Cough(In volunteers) in China (PO, Capsule)